These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 31671770)

  • 1. Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain.
    Grajales D; Ferreira V; Valverde ÁM
    Cells; 2019 Oct; 8(11):. PubMed ID: 31671770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics and glucose homeostasis.
    Bergman RN; Ader M
    J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism.
    Melkersson KI; Dahl ML; Hulting AL
    Psychopharmacology (Berl); 2004 Aug; 175(1):1-6. PubMed ID: 15221198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
    Newcomer JW
    J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia.
    Atti AR; Ferrari Gozzi B; Zuliani G; Bernabei V; Scudellari P; Berardi D; De Ronchi D; Tarricone I; Menchetti M
    Int Psychogeriatr; 2014 Jan; 26(1):19-37. PubMed ID: 24103643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor.
    Weston-Green K; Huang XF; Deng C
    CNS Drugs; 2013 Dec; 27(12):1069-80. PubMed ID: 24114586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms.
    Gonçalves P; Araújo JR; Martel F
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):1-16. PubMed ID: 25523882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study focuses in on potential cause of antipsychotic-induced diabetes.
    O'Neill MF
    Drug News Perspect; 2005 Oct; 18(8):481-2. PubMed ID: 16391716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.
    Melkersson KI; Hulting AL; Brismar KE
    J Clin Psychiatry; 1999 Nov; 60(11):783-91. PubMed ID: 10584769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.
    Hasnain M; Vieweg WV; Hollett B
    Postgrad Med; 2012 Jul; 124(4):154-67. PubMed ID: 22913904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current views on the metabolic syndrome and the effects of antipsychotic drugs].
    Fodor M
    Psychiatr Hung; 2011; 26(3):196-200. PubMed ID: 21799222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults.
    Citrome L; Kalsekar I; Baker RA; Hebden T
    Curr Med Res Opin; 2014 Aug; 30(8):1629-41. PubMed ID: 24666104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
    Yogaratnam J; Biswas N; Vadivel R; Jacob R
    East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.
    Conley RR; Kelly DL
    Isr J Psychiatry Relat Sci; 2005; 42(1):51-60. PubMed ID: 16134407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study.
    Rettenbacher MA; Hummer M; Hofer A; Baumgartner S; Ebenbichler C; Edlinger M; Kemmler G; Lechleitner M; Wolfgang Fleischhacker W
    J Psychopharmacol; 2007 Jun; 21(4):400-4. PubMed ID: 17050656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics and glucose metabolism: how brain and body collide.
    Kowalchuk C; Castellani LN; Chintoh A; Remington G; Giacca A; Hahn MK
    Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E1-E15. PubMed ID: 29969315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view.
    Ferreira V; Grajales D; Valverde ÁM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158534. PubMed ID: 31672575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology.
    Rojo LE; Gaspar PA; Silva H; Risco L; Arena P; Cubillos-Robles K; Jara B
    Pharmacol Res; 2015 Nov; 101():74-85. PubMed ID: 26218604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.